Baring Private Equity Asia | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Baring Private Equity Asia
FDA

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

Inke S.A: APIs manufacturing plant.

Contact Supplier

xyz-pharma-m-2025-04-21

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Baring Private Equity Asia

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 2 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
2 News #PharmaBuzz

INSPECTIONS & REGISTRATIONS

3 FDA, 2 EDQM

3 FDA
2 EDQM

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

3 All

01 1Bushu Pharmaceuticals Ltd

02 2Bushu Pharmaceuticals Ltd.

filter District Decision Reset all filters

3 All

01 3Voluntary Action Indicated

filter Inspection End Date Reset all filters

3 All

01 12017-02-02

02 12013-10-25

03 12010-07-15

filter City Reset all filters

3 All

01 2Kawagoe-Shi

02 1Kodama-Gun

filter Country/Area Reset all filters

3 All

01 3JP

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

AACR Annual meeting

Not Confirmed

FDA Audited

USA

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-02-02

Bushu Pharmaceuticals

City : Kodama-Gun

State :

Country/Area : JP

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2017-02-02

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

AACR Annual meeting

Not Confirmed

FDA Audited

USA

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-10-25

Bushu Pharmaceuticals

City : Kawagoe-Shi

State :

Country/Area : JP

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-10-25

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

AACR Annual meeting

Not Confirmed

FDA Audited

USA

AACR Annual meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-07-15

Bushu Pharmaceuticals

City : Kawagoe-Shi

State :

Country/Area : JP

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-07-15

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!